Antiviral Research

Aims & Scope

Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals.

Its scope encompasses: antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action; new or improved vaccines against viral infections of humans; assessments of drug and vaccine safety; evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures; identification and validation of new drug targets; laboratory animal models of viral diseases; pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4
2024	4.50

Journal Rank

Year	Value
2024	3573

Journal Citation Indicator

Year	Value
2024	2014

SJR (SCImago Journal Rank)

Year	Value
2024	1.195

Quartile

Year	Value
2024	Q1

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

  Citation: 1532

  Authors: Leon, Julian D., Mike G., David A., Kylie M.

• The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

  Citation: 1435

  Authors: B., C., X., B., N.G., E.

• Present and future arboviral threats

  Citation: 1188

  Authors: Scott C., William K.

• Favipiravir (T-705), a novel viral RNA polymerase inhibitor

  Citation: 873

  Authors: Yousuke, Brian B., Kazumi, Kimiyasu, Donald F., Dale L.

• Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

  Citation: 751

  Authors: Ka-Tim, Alvina Yin-Lam, Prathanporn, Sin Fun, Dongdong, Kenrie Pui Yan, Daniel Ka Wing, Michael Chi Wai, Peter Pak-Hang, Xuhui, Malik, Hui-Ling

• Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity

  Citation: 716

  Authors: Dennis A., Naomi L., Douglas M., Alexander J., Chris A., Mike

• The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds

  Citation: 695

  Authors: Yahira M., Sarah E., Andrew D.

• Coronavirus membrane fusion mechanism offers a potential target for antiviral development

  Citation: 680

  Authors: Tiffany, Miya, Javier A., Gary R., Susan

• Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein

  Citation: 594

  Authors: Jian, Yuri, Rolf

• Zika virus: History, emergence, biology, and prospects for control

  Citation: 575

  Authors: Scott C., Federico, Mariano A., Albert I., Guilherme S., George, Pei-Yong, Nikos

---